Welcome to our dedicated page for HealWELL AI news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HealWELL AI stock.
HealWELL AI Inc. (HWAIF) is a leader in AI-powered healthcare solutions focused on improving preventative care through advanced clinical decision support systems. This page serves as the definitive source for official company updates, providing stakeholders with timely insights into strategic developments shaping the future of medical technology.
Investors and industry professionals will find curated press releases covering earnings announcements, strategic partnerships, and technology advancements. Our repository includes updates on regulatory milestones, research collaborations, and AI-driven product innovations that enhance early disease detection capabilities.
All content is rigorously verified to ensure accuracy and relevance for financial analysis and market research. Bookmark this page for direct access to HWAIF's latest progress in transforming healthcare through artificial intelligence and data science applications.
HEALWELL AI (OTCQX: HWAIF) has announced the global launch of AmadeusAI, a significant milestone in integrating DARWEN™ AI technology with Orion Health's Amadeus platform. The enhanced platform introduces the SMARTSuite of AI tools, including SMARTSearch, SMARTSummary, and SMARTIdentify.
AmadeusAI builds upon Orion Health's established Amadeus Digital Care Record, which has served over 150 million patients across 15 countries. The platform consolidates health and social care data into a comprehensive patient view, enabling healthcare providers to analyze clinical data, identify at-risk patients, and make informed decisions at the point of care.
The upgrade is now available to existing Amadeus customers, representing a key proof point of the Orion Health acquisition's success. The platform has been previously deployed across major healthcare systems including NHS Integrated Care Systems, U.S. Health Information Exchanges, and various national health networks.
HEALWELL AI (OTCQX: HWAIF), a healthcare artificial intelligence company specializing in preventative care, will present at the 2025 Cantech Investment Conference on October 9, 2025, in Toronto. The company's presentation is scheduled for 2:00 PM EST at the Arcadian Loft.
Dr. Alexander Dobranowski, President, and Anthony Lam, CFO, will deliver an investor presentation and conduct one-on-one meetings with investors. Additionally, Dr. Dobranowski will participate in the Lunch Keynote Panel titled "AI Investment Opportunities", where he will discuss HEALWELL's capital allocation strategy and recent growth.
HEALWELL AI (OTCQX: HWAIF) announced that its subsidiary Intrahealth Systems has been selected by Public Health Sudbury & Districts to implement Profile, an enterprise-grade electronic medical record platform. The implementation aims to enhance public health infrastructure across Sudbury and Manitoulin districts.
Profile will support various public health programs including infectious disease control, vaccination management, sexual health services, health promotion, oral health programs, and environmental health. The platform features advanced capabilities such as predictive analytics, integrated telemedicine, real-time reporting, and client self-service features.
The system ensures compliance with privacy frameworks including PHIPA, HIPAA, and PIPEDA, while offering robust disaster recovery and mobile functionality. Profile is already deployed across many Ontario public health units and will help improve administrative efficiency, enhance data quality, and increase accessibility through digital portals.
HEALWELL AI (OTCQX: HWAIF) reported exceptional Q2-2025 results, with revenue surging 645% to $40.5 million compared to $5.4 million in Q2-2024. The company achieved its first positive Adjusted EBITDA of $1.9 million, marking a significant turnaround from a $3.7 million loss in Q2-2024.
The growth was primarily driven by the Orion Health acquisition, which contributed to a 1,064% year-over-year increase in Healthcare Software business. The company maintained a strong financial position with $19 million in cash as of June 30, 2025. HEALWELL's Board is seeking strategic alternatives for clinical research and patient services units to transform into a pure-play digital SaaS and AI company.
Notable achievements include a gross margin of 52.5%, strategic expansion into the U.S. market, and full acquisition of Pentavere. The AI segment showed strong momentum with $5.1 million in revenue for H1 2025, representing 223% year-over-year growth.
HEALWELL AI (OTCQX:HWAIF), a healthcare artificial intelligence company specializing in preventative care, will release its Fiscal Second Quarter 2025 financial results on August 13, 2025.
The company will host a conference call and simultaneous webcast at 1:00 PM ET on the same day. The call will feature CEO James Lee, President Dr. Alexander Dobranowski, and CFO Anthony Lam discussing the quarterly results.
HEALWELL AI (OTCQX: HWAIF) reported significant growth in its AI business segment, with preliminary revenues expected to exceed $5 million for H1 2025, representing a 200% year-over-year increase. The company has exercised its call option to acquire the remaining 49% stake in Pentavere Research Group for approximately $14 million, paid through the issuance of 10.16 million Subordinate Voting Shares.
Under new CEO James Lee's leadership, HEALWELL's AI division, including Pentavere, Khure Health, and Mutuo Health Solutions, is expected to achieve positive Adjusted EBITDA in H1 2025. Both Pentavere and Khure have shown over 100% organic revenue growth in the first half of 2025. The company plans to integrate its AI and data science products deeper into its software platforms, leveraging Pentavere's DARWEN™ platform for preventative care solutions.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), a healthcare AI company specializing in preventative care, has announced the voting results from its Annual General Meeting held on June 30, 2025. The meeting saw a 71% shareholder participation rate either in person or by proxy.
All proposed matters were successfully passed, including fixing the board size at six directors and the appointment of Deloitte LLP as the company's new external auditor, replacing PricewaterhouseCoopers LLP. The auditor appointment received 99.98% approval from shareholders.
All six incumbent directors were re-elected with overwhelming support, each receiving over 99% approval. The directors include Alexander Dobranowski, Hamed Shahbazi, Erik Danudjaja, Ian McCrae, Sam Englebardt, and Tina Raja.